Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
1.900
-0.070 (-3.55%)
Aug 14, 2025, 2:20 PM - Market open

Gossamer Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
432205206205854701
Upgrade
Market Cap Growth
37.18%-0.34%0.56%-76.06%21.87%-26.45%
Upgrade
Enterprise Value
4208293118673329
Upgrade
Last Close Price
1.970.900.912.1711.319.67
Upgrade
PS Ratio
11.101.79----
Upgrade
PB Ratio
-6.953.2816.947.032.19
Upgrade
P/TBV Ratio
-6.953.2816.947.032.19
Upgrade
EV/Sales Ratio
10.430.71----
Upgrade
Debt / Equity Ratio
-4.406.883.3918.691.530.57
Upgrade
Asset Turnover
0.130.37----
Upgrade
Quick Ratio
4.116.665.755.198.1613.27
Upgrade
Current Ratio
4.406.895.945.328.3213.51
Upgrade
Return on Equity (ROE)
-783.37%-122.54%-480.50%-343.53%-105.85%-72.30%
Upgrade
Return on Assets (ROA)
-29.63%-11.94%-37.17%-44.34%-30.58%-27.25%
Upgrade
Return on Capital (ROIC)
-41.64%-14.75%-42.34%-50.17%-33.30%-29.36%
Upgrade
Earnings Yield
-32.28%-27.58%-87.42%-112.15%-27.39%-34.71%
Upgrade
FCF Yield
-35.92%-1.69%-77.38%-91.64%-22.29%-25.37%
Upgrade
Buyback Yield / Dilution
-4.00%-48.23%-80.46%-13.00%-9.24%-25.16%
Upgrade
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q